当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 现金流量表

润达医疗

(603108)

  

流通市值:79.87亿  总市值:79.87亿
流通股本:6.04亿   总股本:6.04亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,771,453,008.628,428,657,472.686,241,287,710.634,137,668,742.08
  收到的税费返还4,623,517.112,128,631.698,813,577.046,211,441.02
  收到其他与经营活动有关的现金48,058,112.74115,995,060.8487,228,428.7455,853,491.18
  经营活动现金流入小计1,824,134,638.468,556,781,165.216,337,329,716.414,199,733,674.28
  购买商品、接受劳务支付的现金1,408,094,791.746,126,277,018.844,534,865,275.993,112,027,242.63
  支付给职工以及为职工支付的现金174,393,116.24701,383,374.7542,047,242.01380,185,425.24
  支付的各项税费74,933,782.62362,760,277.05281,943,483.62205,064,270.9
  支付其他与经营活动有关的现金120,534,205.83729,138,283.85539,529,562.86348,660,093.21
  经营活动现金流出小计1,777,955,896.437,919,558,954.445,898,385,564.484,045,937,031.98
  经营活动产生的现金流量净额46,178,742.03637,222,210.77438,944,151.93153,796,642.3
二、投资活动产生的现金流量:
  收回投资收到的现金141,800,000497,040,000292,390,000154,640,000
  取得投资收益收到的现金437,469.9655,080,960.5854,214,972.5443,300,161.81
  处置固定资产、无形资产和其他长期资产收回的现金净额1,062,740.6317,818,283.6211,636,630.156,655,797.08
  收到的其他与投资活动有关的现金954,841.131,500,5501,500,5501,500,550
  投资活动现金流入小计144,255,051.72571,439,794.2359,742,152.69206,096,508.89
  购建固定资产、无形资产和其他长期资产支付的现金39,102,091.85250,484,597.64134,130,639.3456,690,397.78
  投资支付的现金131,916,130.15559,775,708.93368,103,353.15136,408,742.86
  支付其他与投资活动有关的现金96,642,201.19643,594.97430,410.63294,551.73
  投资活动现金流出小计267,660,423.19810,903,901.54502,664,403.12193,393,692.37
  投资活动产生的现金流量净额-123,405,371.47-239,464,107.34-142,922,250.4312,702,816.52
三、筹资活动产生的现金流量:
  吸收投资收到的现金-154,285.71154,285.71154,285.71
  其中:子公司吸收少数股东投资收到的现金-154,285.71154,285.71154,285.71
  取得借款收到的现金2,064,673,791.57,579,526,469.125,504,120,782.523,821,142,957.2
  收到其他与筹资活动有关的现金200,515,497402,248,095362,930,000229,680,000
  筹资活动现金流入小计2,265,189,288.57,981,928,849.835,867,205,068.234,050,977,242.91
  偿还债务支付的现金2,106,820,591.957,685,740,098.45,695,076,556.674,040,624,403.29
  分配股利、利润或偿付利息支付的现金92,481,401.55420,996,611.98326,355,295.33194,782,348.15
  其中:子公司支付给少数股东的股利、利润41,411,805.26139,647,221.05106,180,00071,875,500
  支付其他与筹资活动有关的现金165,856,279.81494,596,421.9338,469,552.17218,129,404.49
  筹资活动现金流出小计2,365,158,273.318,601,333,132.286,359,901,404.174,453,536,155.93
  筹资活动产生的现金流量净额-99,968,984.81-619,404,282.45-492,696,335.94-402,558,913.02
四、汇率变动对现金及现金等价物的影响-587,367.3-319,395.78226,848.13,570,941.43
五、现金及现金等价物净增加额-177,782,981.55-221,965,574.8-196,447,586.34-232,488,512.77
  加:期初现金及现金等价物余额667,045,710.31889,011,285.11889,011,285.11889,011,285.11
  期末现金及现金等价物余额489,262,728.76667,045,710.31692,563,698.77656,522,772.34
补充资料:
  净利润--518,150,880.46--99,482,170.05
  资产减值准备-208,737,137.88-45,795.63
  固定资产和投资性房地产折旧-286,439,547.75-142,302,639.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-286,439,547.75-142,302,639.19
  无形资产摊销-21,910,565.24-10,244,900.18
  长期待摊费用摊销-28,163,963.57-13,938,170.7
  处置固定资产、无形资产和其他长期资产的损失--3,119,148.21-958,792.77
  固定资产报废损失-3,571,120.88-240,583.09
  财务费用-279,777,407.24-138,203,412.23
  投资损失--20,792,097.98--47,447,216.74
  递延所得税--56,595,188--17,603,552.94
  其中:递延所得税资产减少--56,818,983.7--16,683,168.13
    递延所得税负债增加-223,795.7--920,384.81
  存货的减少--521,072,010.81--259,001,591.83
  经营性应收项目的减少--70,246,852.02--178,485,255.71
  经营性应付项目的增加-748,943,020-348,666,438.55
  现金的期末余额-667,045,710.31-656,522,772.34
  减:现金的期初余额-889,011,285.11-889,011,285.11
  现金及现金等价物的净增加额--221,965,574.8--232,488,512.77
公告日期2026-04-292026-04-292025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑